[1]
J. P. M. N. Correa, “CARDIOVASCULAR RISKS ASSOCIATED WITH THE SYSTEMIC USE OF NAPHAZOLINE: AN INTEGRATIVE REVIEW”, Editora, pp. 598–610, Dec. 2025, Accessed: Jan. 11, 2026. [Online]. Available: https://sevenpubl.com.br/editora/article/view/8751